Results per Page:
Identification of potent and broadly-neutralizing antibodies against sarbecoviruses including SARS-CoV-1 and SARS-CoV-2
From the Overbaugh lab, Human Biology Division
Crunching the numbers for next-gen COVID-19 vaccines
BARDA taps Fred Hutch biostatisticians to assess new vaccine technology, more nimble trial design
¿Necesito otra vacuna de refuerzo contra el SRAS-CoV-2?
Del Dr. Bo Zhang y laboratorios colaboradores, División de Vacunas y Enfermedades Infecciosas
Long COVID: key risk factors in postmenopausal women
From the Neuhouser research group, Public Health Sciences Division
Do I need another SARS-CoV-2 booster vaccine?
From Dr. Bo Zhang and collaborating labs, Vaccine & Infectious Disease Division
A new era of COVID-19 brings new outlooks for cellular therapy recipients
From the Liu Group, Vaccine and Infectious Disease Division
The exclusion of immunocompromised patients in clinical trials and how we can do better
From Drs. Michael Boeckh, Joshua Hill, Steven Pergam and Larry Corey, Hematologic Malignancies and Cancer Immunology Programs of the Cancer Consortium
A method to predict how a virus might spread through a population
From the Bedford Lab, Vaccine and Infectious Disease Division
Dedicated supporters at the Heart of the Hutch
Using creativity and passion to support Fred Hutch research in good times and bad
SARS-CoV-2 vaccine efficacy in Latin American countries
From the Gilbert Group, Vaccine and Infectious Disease and Public Health Sciences Divisions
A coordinated care approach rapidly gets COVID-19 therapy into the hands of high-risk cancer patients
From Drs. Eduardo Sanchez, Steven Pergam, and Catherine Liu, ,Fred Hutch Vaccine and Infectious Diseases Division and Cancer Consortium Hematologic Program
Differential immune responses between mothers and their infants to SARS-CoV-2
From the Overbaugh and Lehman Groups, Human Biology Division
A promising HIV vaccine candidate gets a little help
New strategy stirs a robust response from T cells tracked by McElrath lab
Infectious disease scientists look beyond the pandemic
A symposium about protecting people with weakened immune systems from microbial threats
Social workers illustrate the Heart of the Hutch
Hundreds of people keep Fred Hutch science and support services going. Here are some of their stories.
A pseudovirus system to fight viral antibody escape
From the Bloom Lab, Basic Sciences and Public Health Sciences Divisions
Going long: Viruses linger with lasting impact
Herpes, HIV, Epstein-Barr and other viruses hang around, causing potential long-term health woes. Should ‘long COVID’ surprise us?
A win for vaccines: immune correlates identified for COVID-19
From the Fong, Gilbert, and collaborating labs, Vaccine and Infectious Disease Division & Public Health Sciences Division
Working the holidays at Fred Hutch
Cancer doesn't take the holidays off and neither does Fred Hutch